GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Dr. Ashkan Shoamanesh

Photo of Ashkan  Shoamanesh
Ashkan Shoamanesh Dr.
Investigator

Current Positions

  • Director of Hemorrhagic Stroke Research Program and Investigator, Stroke and Cognition Program at Population Health Research Institute
  • Assistant Professor of Medicine (Neurology), McMaster University
  • Inaugural Marta and Owen Boris Chair in Stroke Research and Care, McMaster University
  • Director, Stroke Fellowship Program at Hamilton Health Sciences / McMaster University

Bio

Dr. Shoamanesh is the founding Director of the Hemorrhagic Stroke Research Program within the Stroke and Cognition Program at the Population Health Research Institute at Hamilton Health Sciences.  He is a Stroke Neurologist who completed his residency at the University of British Columbia in 2012, followed by fellowship training at the Boston University School of Medicine (2012-13) and Harvard Medical School (2013-14).  He is an Assistant Professor of Medicine (Neurology) at McMaster University, where he holds the Marta and Owen Boris Chair in Stroke Research and Care and serves as Director of the Stroke Fellowship Program. 

His main research focus is the characterization of hemorrhage-prone cerebral small vessel disease and the optimization of clinical care in this patient population.  Dr. Shoamanesh is currently a consultant within the Framingham Heart Study and works in the Project Teams for the NAVIGATE ESUS, INTERSTROKE, COMPASS MIND and INVICTUS trials. He is Co-Principal Investigator of the NASPAF-ICH trial (a phase II multicenter randomized trial investigating optimal antithrombotic therapy in patients with high-risk atrial fibrillation and previous intracranial hemorrhage), and Canadian National Principal Investigator of the SATURN randomized trial (a phase III international trial comparing continuation vs. discontinuation of statin therapy in lobar intracerebral hemorrhage survivors on statins at the time of their hemorrhage).  He is Co-Principal Investigator and Chair of the Canadian HEmorrhagic Stroke TrIals IniatiVE (CoHESIVE; www.phri.ca/cohesive/), which is a Canada-centric international collaborative network of 50+ investigators devoted to the development and efficient execution of hemorrhagic stroke trials, and to bettering the lives of hemorrhagic stroke survivors. Dr. Shoamanesh has been tasked with leading the inaugural Heart and Stroke Foundation Canadian Stroke Best Practice Recommendations on the Management of Spontaneous Intracerebral Hemorrhage.

Dr. Shoamanesh has published a large number of manuscripts in leading scientific journals. His work has been recognized by, amongst others, the 2014 European Stroke Conference Young Investigator Award and the 2015 American Heart/Stroke Association (AHA/ASA) Mordecai Y.T. Globus New Investigator Award.  He has been selected to receive the prestigious AHA/ASA Robert G. Siekert New Investigator Award in Stroke at the 2019 International Stroke Conference, which is awarded to encourage the ongoing stroke-related research of an outstanding young scientist.

NAVIGATE ESUS

COMPASS MIND

INVICTUS

NASPAF-ICH

Publications are listed in chronological order by descending date. Link takes user to pubMed for publication details.